2Rubattu S, Stanzione R, Angelantonio ED, et al. Atrial natriuretic peptide gene polymorphisms and risk of ischemic stroke in humans [J]. Stroke,2004,35 (4) :814 -818.
3Sara N,Tanaka Y, Suzuki S, et al. Effectiveness of angiotensin converting enzyme inhibitor or angiotensin receptor blocker on atrial natriuretic peptide[ J ]. Cite J ,2003,67 ( 12 ) : 1053 - 1058.
4Sengenes C, Zakaroff-Girard A, Moulin A, et al. Natriuretie peptide-dependent lipolysis in fat cells is a primate specificity [ J ]. Am J Physiol Regul lntegr Cornp Physiol,2002,283 (1) :257 -265.
5Ktinger JR,Pietras L,Warburton R, et al. Reduced oxygen tension increases atrial natriuretic peptide release from atrial eardiocytes [ J ]. Exp Bio Med,2001,226(9) :847 -853.
6Hamad AM, Clayton A, Islam B, et al. Guanylyl cyclases, nitric oxide, natriuretic peptides, and airway smooth muscle function [ J ]. AJP Lung Physiol,2003,285 ( 5 ) : 973 - 983.
7Wang TJ,LarsonG, Levy D, et al. Impact of obesity on plasma natriuretic peptide levels 13 [ J ]. Circulation,2004,109 ( 5 ) :594 - 600.
8Melo LG,Steihelper ME,Pang SC,et al. ANP in regulation of arterial pressure and fluld-electrolyte balance: lessons from genetic mouse models [ J ]. Physiol Genomic, 2000,3 ( 1 ) :45 - 58.
9Walther T, Olah L, Hortnag H, et al. lschemie injury in experimental stroke depends on angiotensin II[ J ]. Faseb J ,2002,16 (2) :169 - 176.
10Schrader J, Kulschewski A, Dendorfer A. Inhibition of the renin-angiotensin system and the prevention of stroke [ J ]. Am J Cardiovasc Drugs ,2007,7 ( 1 ) :25 - 37.
